HUMAN Gesellschaft für Biochemica und Diagnostica mbH acquired LABiTec GmbH
Frankfurt, January 2014. CFP BioConnect – now ACXIT Capital Partners – acted as sole financial advisor to HUMAN Gesellschaft für Biochemica und Diagnostica mbH, based in Wiesbaden/Germany, on the acquisition of the entire share capital of LABiTec LAbor BioMedical Technologies GmbH (“LABiTec”), based in Ahrensburg/Germany.
LABiTec specializes on the development, manufacturing and distribution of diagnostic analyzers and consumables, with main focus on clinical coagulation, point of care testing and platelet-function (aggregation) diagnostic systems.
With this strategic move, HUMAN strengthens its internal technological competence for the development and production of diagnostic coagulation analyzers and broadens its product offering with a fully automatic machine. Financial terms of the transaction were not disclosed.
This transaction further enhances CFP BioConnect’s track record in the diagnostics industry and adds HUMAN as an important global player in the IVD market to its list of customers.
ACXIT Capital Partners is a leading independent corporate finance and investment advisory firm for mid-market clients and entrepreneurs in Europe and beyond. Since 1998, ACXIT offers its clients comprehensive corporate finance advisory services including M&A and capital markets advisory as well as restructuring, equity/debt and strategic advisory. As an independent, privately owned firm we maintain offices and representations in Frankfurt, Berlin, Munich, Leipzig, Zurich, Hong Kong and New York, as well as strong alliances in France, China and India. (www.acxit.com)
ACXIT Capital Holding GmbH
Bockenheimer Landstraße 24
60323 Frankfurt am Main
Dr. Hartmut Vennen
Senior Managing Director, Strategic Communications
Park Tower | Bockenheimer Anlage 44
60322 Frankfurt am Main
Phone: +49 69 92037 137
Mobile: +49 160 895 5858